Clinical Trials

Phase NA Enrolling by invitation

Esophageal Neoplasms

NCT06048926 2023-09-21

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

30 enrolled

Esophageal Squamous Cell Carcinoma

NCT01367301 2023-08-21

Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer

Phase NA Terminated

14 enrolled 5 charts

GynecologicSarcoma

Stage IA Uterine Sarcoma

NCT00656669 2023-05-23

Exploratory Study of Sunitinib Malate as a Component of Neoadjuvant Therapy for Breast Cancer

23 enrolled 12 charts

Breast Neoplasms

NCT01755897 2023-05-09

CC-01

337 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04047953 2023-04-05

Paclitaxel (Albumin-bound) Combined With Oxaliplatin and S-1 Conversion Therapy for Gastric Adenocarcinoma

Phase NA Recruiting

95 enrolled

Stomach Neoplasms

NCT01821833 2022-10-05

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

60 enrolled

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pain, Peripheral Nervous System Diseases

NCT01643460 2022-04-14

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

33 enrolled

Pancreatic Intraductal Neoplasms, Neoplasms, Pancreatic Cyst, Cystadenocarcinoma, Mucinous, Cystadenoma, Mucinous

NCT05228743 2022-02-08

Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer

180 enrolled

Stomach Neoplasms

NCT04519905 2021-11-02

Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)

Phase NA Recruiting

320 enrolled

Esophageal Squamous Cell Carcinoma

NCT04324346 2021-03-18

PICC&PAC

250 enrolled

Infections, Thrombosis

NCT04443036 2020-06-23

Clinical Study of Nab-paclitaxel Combined With Toripalimab in Local Advanced or Metastatic G/GEJ Carcinoma

44 enrolled

Stomach Neoplasms

NCT02640053 2019-09-30

Topical Cryotherapy in Reducing Pain in Patients With Chemotherapy Induced Peripheral Neuropathy or Paclitaxel Induced Acute Pain Syndrome

46 enrolled 13 charts

Breast Neoplasms

NCT01144442 2019-07-30

WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer

Phase NA Terminated

10 enrolled 7 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT03544047 2018-12-11

Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid Model

50 enrolled

Organoid

NCT03756090 2018-12-07

PECP

100 enrolled

Breast Diseases, Breast Neoplasms

NCT00580983 2016-09-07

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

90 enrolled 11 charts

Head & Neck

Head and Neck Neoplasms

NCT02102438 2016-08-31

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Phase NA Withdrawn

Breast Neoplasms

NCT02637375 2016-05-30

A Pilot Preoperative Trial of Ganetespib With Paclitaxel for Triple-Negative Breast Cancer

Phase NA Withdrawn

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00617370 2015-12-23

Dose-Dense Epirubicin and Cyclophosphamide (EC) Followed by Paclitaxel in Breast Cancer: Feasibility

38 enrolled

Breast Neoplasms

NCT01209520 2015-02-24

Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy

6 enrolled 6 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Carcinogenesis

NCT02365935 2015-02-19

4 Versus 6 Courses of Adjuvant Chemotherapy in LACC Patients Previously Treated With NACT Plus Radical Surgery

215 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT01848197 2013-05-07

PATEN

1,000 enrolled

Breast Neoplasms

NCT00544167 2013-04-01

Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer

45 enrolled 5 charts

Breast Neoplasms

NCT00538395 2011-12-13

Intensive Sequential Chemotherapy With Adriamycin Taxol and Cytoxan in the Treatment of Locally Advanced Breast Cancer

100 enrolled